Description:
Herti is a HER2-targeted monoclonal antibody indicated for the treatment of HER2-positive breast and gastric cancers. It binds to the HER2 receptor, inhibiting downstream signaling pathways that drive cancer cell growth and survival.
Herti is used in both early-stage and metastatic settings, often as part of combination regimens. It is a cornerstone in personalized therapy for HER2-positive patients, improving survival outcomes and quality of life.
Share your experience with our medical product. Write a review!
24 Dec 2025
Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness
(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)
16 Dec 2025
Top 7 Everyday Foods That Trigger Acidity - And How Jeerafast Helps You Enjoy Meals Without the Burn
(A complete Indian-friendly guide for digestion, bloating, acidity, and natural relief)
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
